Tumor necrosis could reflect advanced disease status in patients with diffuse large B cell lymphoma treated with R-CHOP therapy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Moo-Kon,Song

第一单位： Department of Hematology-Oncology, Hanyang University Hanmaeum Changwon Hospital, Changwon, Korea.

作者： Moo-Kon,Song ^[1] ; Joo-Seop,Chung ^[2] ; Dong-Yeop,Shin ^[3] ; Sung-Nam,Lim ^[4] ; Gyeong-Won,Lee ^[5] ; Jae-Cheol,Choi ^[6] ; Won-Young,Park ^[7] ; So-Yeon,Oh ^[8]

作者单位： Department of Hematology-Oncology, Hanyang University Hanmaeum Changwon Hospital, Changwon, Korea. ^[1] Department of Hematology-Oncology, Pusan National University Hospital Medical Research Institute, 1-10 Ami-dong, Seo-gu, Busan, 602-739, Republic of Korea. song9676@hanmail.net. ^[2] Department of Hematology, Seoul National University Hospital, Seoul, Korea. ^[3] Department of Hematology, Busan Haeundae Paik Hospital, Busan, Korea. ^[4] Department of Hematology, Gyeong-Sang National University Hospital, School of medicine, Gyeong-Sang National University, Jinju, Korea. ^[5] Department of Laboratory Medicine, Hanyang University Hanmaeum Changwon Hospital, Changwon, Korea. ^[6] Department of Pathology, Hanyang University Hanmaeum Changwon Hospital, Changwon, Korea. ^[7] Department of Hematology-Oncology, Pusan National University Yangsan Hospital, Yangsan, Korea. ^[8]

关键词 Ann Arbor stage Diffuse large B cell lymphoma Survival Tumor necrosis